Solomon Islands National Provident Fund (SINPF) is supporting the fight against cancer in the country by donating five ...

Of the 2.3 million women diagnosed annually with breast cancer worldwide, research shows more than half report having ...

First orphan designation ever granted to a condensate-modulating therapeuticBuilds on recent IND opening for DPTX3186, a ...

NetworkNewsWire Editorial Coverage NEW YORK, Oct. 29, 2025 /PRNewswire/ -- The global cancer-therapy landscape is undergoing a rapid evolution toward ...

Dermatologic side effects from breast cancer treatments include chemotherapy-induced allergic reactions and drug-specific effects like hand-foot syndrome, and immunotherapy-related immune skin ...

Merck on Tuesday said a Phase 3 study evaluating the dual oral regimen of Welireg plus Lenvima met one of its primary endpoints of progression-free survival for the treatment of patients with advanced ...

The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity and improve ...

WHEN a kiss from Sarah Susak’s husband gave her what felt like an electric shock, she didn’t think much of it. But the ...

As part of the Daily Express's Cancer Care campaign, Robert Fisk offers a candid look at life battling the disease.

The FDA rounded out the month with the approval of remibrutinib (Rhapside; Novartis), a highly selective Bruton tyrosine kinase inhibitor (BTKi), for patients with chronic spontaneous urticaria (CSU) ...

NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in ...

Amid steady Q3 growth, Roche's giredestrant-Afinitor combo extended survival in advanced ER-positive, HER2-negative early breast cancer.